FDA Clearance Tracker · K260771
TruSelect 2.6 Microcatheter
Last checked: Nov 20, 2026Latest source record: May 15, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 15, 2026
Substantially Equivalent
Time to decision
67 days
Received Mar 9, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K260771
- Device name
- TruSelect 2.6 Microcatheter
- Applicant
- Boston Scientific Corporation
- Applicant location
- Marborough, MA
- Received
- Mar 9, 2026
- Decided
- May 15, 2026
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Catheter, Continuous Flush (KRA)
- Device class
- Class II
- Regulation
- 21 CFR 870.1210
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code KRA. The earliest in FDA's data is K761273, decided Jan 12, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K260771
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Boston Scientific Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- SpaceOAR Flex System510(k)
K262151 · Decided Sep 11, 2026 · 78 days after receipt
Device type: Hydrogel Spacer (OVB) · Radiology & Imaging
K261153 · Decided Aug 26, 2026 · 140 days after receipt
Device type: Ureteroscope And Accessories, Flexible/Rigid (FGB) · GI, Urology & Nephrology
K261915 · Decided Aug 4, 2026 · 56 days after receipt
Device type: Endoscopic Access Overtube, Gastroenterology-Urology (FED) · GI, Urology & Nephrology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.